Monthly Archives - November 2017

01Nov

Siamab Therapeutics Presents New PreClinical Safety Data

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced the presentation of new preclinical data demonstrating the safety of its novel anti-Sialyl-Tn (STn) antibody drug conjugates (ADCs) in multiple animal models, including non-human primates (NHPs). These results add to the company’s efficacy data findings showing that its anti-STn antibody therapeutics inhibit tumor progression in cell-line-derived and patient-derived xenograft (PDX) ovarian cancer and pancreatic cancer mouse models, with complete regression observed in some treatment arms. The preclinical efficacy...
Portfolio News
Read more...
01Nov

Regroup to Host Live Webinar on Active Shooter Preparedness for Large Venues and High Rises

Regroup Mass Notification, the award-winning leader in emergency and day-to-day communication technology, today announced a joint alliance with Alvarez Associates, industry leader in workplace violence prevention, to present an online webinar on critical strategies for preparing for and responding to active shooter events at large venues. Read more >>
Portfolio News
Read more...